Christopher Smith is a pharmacist who is specialized in Oncology in Vacaville, California. Patients can reach at 1020 Nut Tree Rd Ste 390, Vacaville or contact on 707-624-8000. Active license number of Christopher Smith is 67856 for Oncology in California. Christopher Smith is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Christopher Smith speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Christopher Smith
Specialization:
Oncology
Credentials:
PHARM. D
Gender:
X
Location:
1020 Nut Tree Rd Ste 390, Vacaville, California, 95687-4100
Phone:
707-624-8000
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Christopher Smith are as mentioned below.
NPI Number:
1770477440
NPI Enumeration Date:
05 Jun, 2025
NPI Last Update On:
05 Jun, 2025
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Christopher Smith are as mentioned below.
Specialization
License Number
State
Status
Oncology
67856
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1020 Nut Tree Rd Ste 390, Vacaville, California
Zip:
95687-4100
Phone Number:
707-624-8000
Fax Number:
--
Patients can reach Christopher Smith at 1020 Nut Tree Rd Ste 390, Vacaville, California or can call on phone at 707-624-8000.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.